Kidney transplant recipients who received their organs from donors who died from cardiovascular causes or experienced brain death had similar long-term graft survival and function.
Findings support the use of a fourth COVID-19 vaccine dose in kidney transplant recipients who don’t respond to standard 2-dose vaccination plus 1 booster.
Purpura and ulcers were the most frequent form of clinical presentation of calciphylaxis.
Risk for breakthrough infection higher for those with immunocompromising conditions, such as HIV, rheumatoid arthritis, solid organ transplant
After loss of the first allograft, survival time longer with timely second kidney transplant versus remaining wait-listed and on dialysis
Vaccinated kidney transplant recipients show impaired neutralization against emerging COVID-19 variants of concern.
One dose of Evusheld is administered as 2 separate, consecutive injections and may be effective for 6 months
Up to 30% of all people who receive a kidney transplant develop type 2 diabetes. Researchers investigated reasons why this happens.
Hyperuricemia in this population is typically attributed to low uric acid excretion due to reduced glomerular filtration rates.
Except for rituximab, no increased risk seen for in-hospital death or mechanical ventilation for those on long-term immunosuppressive therapy